All In Biotech

Drug Trial Radar · NCT01959529

A Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Subjects With Type 2 Diabetes at High Risk of Cardiovascular Events

Last checked: Nov 20, 2026Latest source record: Jul 24, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 7,637 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

7,637

Actual

Start

Oct 29, 2013

Primary completion

Oct 16, 2016

Study completion Oct 16, 2016

Sponsor

Lead sponsor
Novo Nordisk A/SNovo Nordisk (NVO)
Sponsor type
Industry
First posted
Oct 10, 2013

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 50 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This trial is conducted globally. The aim of this trial is to compare cardiovascular safety of insulin degludec versus insulin glargine in subjects with type 2 diabetes at high risk of cardiovascular events.

Conditions

  • Diabetes
  • Diabetes Mellitus, Type 2

Interventions

  • insulin degludecDrug

    Injected once daily subcutaneously (s.c., under the skin)

  • insulin glargineDrug

    Injected once daily subcutaneously (s.c., under the skin)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time From Randomisation to First Occurrence of a Major Adverse Cardiovascular Event (MACE): Cardiovascular Death, Non-fatal Myocardial Infarction, or Non-fatal StrokeTime frame: From randomisation to individual end of trial date (maximum patient year observation: 2.75 years)

Locations

446 sites in 20 countries. Site status is shown where the registry gives one.

  • Novo Nordisk Investigational Site

    Birmingham, Alabama

  • Novo Nordisk Investigational Site

    Birmingham, Alabama

  • Novo Nordisk Investigational Site

    Montgomery, Alabama

  • Novo Nordisk Investigational Site

    Montgomery, Alabama

  • Novo Nordisk Investigational Site

    Gilbert, Arizona

  • Novo Nordisk Investigational Site

    Glendale, Arizona

  • Novo Nordisk Investigational Site

    Litchfield Park, Arizona

  • Novo Nordisk Investigational Site

    Phoenix, Arizona

  • Novo Nordisk Investigational Site

    Tucson, Arizona

  • Novo Nordisk Investigational Site

    Tucson, Arizona

  • Novo Nordisk Investigational Site

    Tucson, Arizona

  • Novo Nordisk Investigational Site

    Little Rock, Arkansas

  • Novo Nordisk Investigational Site

    Little Rock, Arkansas

  • Novo Nordisk Investigational Site

    Searcy, Arkansas

  • Novo Nordisk Investigational Site

    Chula Vista, California

  • Novo Nordisk Investigational Site

    Concord, California

  • Novo Nordisk Investigational Site

    Downey, California

  • Novo Nordisk Investigational Site

    Duarte, California

  • Novo Nordisk Investigational Site

    Encino, California

  • Novo Nordisk Investigational Site

    Fresno, California

  • Novo Nordisk Investigational Site

    Greenbrae, California

  • Novo Nordisk Investigational Site

    Huntington Beach, California

  • Novo Nordisk Investigational Site

    Inglewood, California

  • Novo Nordisk Investigational Site

    La Jolla, California

  • Novo Nordisk Investigational Site

    La Mesa, California

  • Novo Nordisk Investigational Site

    Lancaster, California

  • Novo Nordisk Investigational Site

    Long Beach, California

  • Novo Nordisk Investigational Site

    Los Alamitos, California

  • Novo Nordisk Investigational Site

    Mission Hills, California

  • Novo Nordisk Investigational Site

    Montclair, California

  • Novo Nordisk Investigational Site

    Monterey, California

  • Novo Nordisk Investigational Site

    North Hollywood, California

  • Novo Nordisk Investigational Site

    Palm Springs, California

  • Novo Nordisk Investigational Site

    Poway, California

  • Novo Nordisk Investigational Site

    San Diego, California

  • Novo Nordisk Investigational Site

    San Diego, California

  • Novo Nordisk Investigational Site

    San Ramon, California

  • Novo Nordisk Investigational Site

    Santa Ana, California

  • Novo Nordisk Investigational Site

    Sherman Oaks, California

  • Novo Nordisk Investigational Site

    Thousand Oaks, California

Showing 40 of 446 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.